TOP2B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.417400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.983700E-02
Normal-vs-Stage2
1.880380E-03
Normal-vs-Stage3
8.055600E-03
Normal-vs-Stage4
3.423600E-02
Stage1-vs-Stage2
4.887800E-01
Stage1-vs-Stage3
6.027800E-02
Stage1-vs-Stage4
5.881800E-01
Stage2-vs-Stage3
5.151800E-02
Stage2-vs-Stage4
2.663000E-01
Stage3-vs-Stage4
2.035800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.576510E-03
Normal-vs-AfricanAmerican
4.366000E-02
Normal-vs-Asian
1.114960E-01
Caucasian-vs-AfricanAmerican
5.907800E-01
Caucasian-vs-Asian
8.054600E-01
AfricanAmerican-vs-Asian
9.004400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.824290E-03
Normal-vs-Female
5.359100E-03
Male-vs-Female
5.597600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.808600E-01
Normal-vs-Age(41-60Yrs)
3.124800E-03
Normal-vs-Age(61-80Yrs)
3.544300E-03
Normal-vs-Age(81-100Yrs)
4.642900E-04
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.505620E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.113200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.621540E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.705960E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.124300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.792200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.279200E-03
Normal-vs-Daily Drinker
1.422110E-03
Normal-vs-Weekly Drinker
7.877600E-03
Normal-vs-Occasional Drinker
6.097400E-03
Normal-vs-Social Drinker
9.343200E-03
Non Drinker-vs-Daily Drinker
7.752800E-01
Non Drinker-vs-Weekly Drinker
8.971800E-01
Non Drinker-vs-Occasional Drinker
1.666220E-01
Non Drinker-vs-Social Drinker
5.341000E-01
Daily Drinker-vs-Weekly Drinker
7.037000E-01
Daily Drinker-vs-Occasional Drinker
8.507600E-02
Daily Drinker-vs-Social Drinker
3.688200E-01
Weekly Drinker-vs-Occasional Drinker
2.631400E-01
Weekly Drinker-vs-Social Drinker
6.637800E-01
Occasional Drinker-vs-Social Drinker
5.091400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.380000E-01
Normal-vs-Grade 2
8.093600E-01
Normal-vs-Grade 3
8.124200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.149200E-01
Grade 1-vs-Grade 3
5.075000E-01
Grade 1-vs-Grade 4
4.380000E-01
Grade 2-vs-Grade 3
9.420000E-01
Grade 2-vs-Grade 4
8.093600E-01
Grade 3-vs-Grade 4
8.124200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.021200E-03
Normal-vs-NonDiabetic
1.897090E-03
Diabetic-vs-NonDiabetic
9.948200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.020200E-03
Normal-vs-NoPancreatitis
2.679600E-03
Pancreatitis-vs-NoPancreatitis
5.194600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.009810E-02
Normal-vs-N1
1.899300E-03
N0-vs-N1
3.036600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.006000E-02
Normal-vs-TP53-NonMutant
3.564200E-02
TP53-Mutant-vs-TP53-NonMutant
8.246400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
